LAC Med Berhad (KLSE:LACMED)
0.7150
-0.0350 (-4.67%)
At close: Nov 20, 2026
LAC Med Berhad Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, LAC Med Berhad stock has a consensus rating of "Strong Buy" and an average price target of RMĀ 1.16. The average 1-year stock price forecast is 61.54% higher than the current stock price, while the lowest is RMĀ 1.15 (+60.84%) and the highest is RMĀ 1.16 (+62.24%).
Price Target: RMĀ 1.16 (+61.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for LAC Med Berhad stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
259.70M
from 201.66M
Increased by 28.78%
Revenue Next Year
309.40M
from 259.70M
Increased by 19.14%
EPS This Year
0.07
EPS Next Year
0.08
from 0.07
Increased by 20.77%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.